SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 2, 2017

Primary Completion Date

April 9, 2021

Study Completion Date

April 9, 2021

Conditions
Diabetes Mellitus in Pregnancy
Interventions
BEHAVIORAL

SweetMama Focus Groups

Focus groups will assess tool functionality, design, interpretability, and acceptability (initial reaction, attitude, and receptiveness) of SweetMama via qualitative interviewing. The group format will generate feedback on areas that may not be revealed in a one-on-one interview.

BEHAVIORAL

SweetMama Individual Testing

"Women will be oriented to SweetMama use on their own Android- or Apple-based phones. The goals of this phase are to collect data from diverse users that will (1) confirm that the mobile apps are functioning (not crashing) across a wide range of devices and operating systems, (2) provide basic information about app usage and user satisfaction (3) inform the development of future iterations by analyzing participant characteristics and use, and (4) collect quality assurance data that will allow the research team to refine the applications. Women will use SweetMama for 2 weeks, engage in periodic check-ins with the research assistant, and participate in a semi-structured interview upon completion of SweetMama usage."

BEHAVIORAL

SweetMama Feasibility Testing - Pilot Randomized Trial

"Women will be oriented to SweetMama use on their own Android- or Apple-based phones. The goals of this phase are to collect data from diverse users that will determine acceptability, feasibility, and pilot procedures in anticipation of a fully powered randomized controlled trial. Women will use SweetMama from enrollment (early pregnancy) to up to 8 weeks postpartum, engage in periodic check-ins with the research assistant, and participate in surveys and a semi-structured interview upon completion of SweetMama usage."

Trial Locations (1)

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Northwestern University

OTHER

NCT03240874 - SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women | Biotech Hunter | Biotech Hunter